Human Prothrombin Complex Market Analysis to Grow at 11.8% CAGR Will Hit 2430 Million USD in 2025
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
View full press release